ezetimibe has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coticchia, CM; Curatolo, AS; Moses, MA; Pelton, K; Schaffner, CP; Solomon, KR; Zurakowski, D | 1 |
| Boucher, K; Freeman, MR; Joo, J; Kim, J; Pelton, K; Schaffner, CP; Solomon, KR; Tully, C; Zurakowski, D | 1 |
2 other study(ies) available for ezetimibe and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Hypercholesterolemia induces angiogenesis and accelerates growth of breast tumors in vivo.
Topics: Animals; Apoptosis; Azetidines; Cell Line, Tumor; Cell Proliferation; Cholesterol; Cholesterol, Dietary; Diet, High-Fat; Ezetimibe; Female; Humans; Hypercholesterolemia; Mammary Neoplasms, Experimental; Mice, SCID; Neoplasm Transplantation; Neovascularization, Pathologic | 2014 |
Ezetimibe is an inhibitor of tumor angiogenesis.
Topics: Animals; Anticholesteremic Agents; Antineoplastic Agents; Apoptosis; Azetidines; Cell Death; Cholesterol; Ezetimibe; Hemoglobins; Humans; Male; Mice; Microcirculation; Neoplasm Transplantation; Neovascularization, Pathologic; Prostatic Neoplasms; Transplantation, Heterologous | 2009 |